Skip to content
MarketScale
‹ Back to IndustriesHealthcare

As Omicron Variant Spreads, At-Home Tests May Not Be Home for the Holidays

Omicron is the word on everyone’s tongues this holiday season, as the latest COVID-19 variant is surging just as the country enters peak travel dates. Already, airports have seen the most traffic since before the pandemic. The Biden administration has implemented testing requirements, regardless of vaccination status, to all international travelers to help curb the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Omicron is the word on everyone’s tongues this holiday season, as the latest COVID-19 variant is surging just as the country enters peak travel dates. Already, airports have seen the most traffic since before the pandemic. The Biden administration has implemented testing requirements, regardless of vaccination status, to all international travelers to help curb the spread. At-home tests have fast become a popular way for people to check their COVID-status, and the industry is having to adjust quickly as variants develop.

According to Gerald Commissiong, the Chief Executive Officer of Todos Medical, some at-home tests have already been rendered ineffective as the already-existent variants have changed the sequences in the virus.

“We need to start thinking about a completely new set of tests that are able to detect different parts of the virus that do not mutate,” said Commissiong.

Todos Medical is working on their own 3CL protease test that wouldn’t rely on the ever-changing sequence of the virus to detect it.

“That may be a solution to get around a mutating virus,” he said.

Another challenge during the holiday season regarding at-home tests is the delayed delivery times for packages, which could render a test potentially useless if the tested individual later encountered someone with the virus, or if the integrity of the test degraded during the shipping process. He says increasing the number of local labs is a workaround for this situation to help lessen delivery time. Commissiong spoke highly of the vaccines, though stressed that they are designed to prevent hospitalization and death.

“If you get sick, you’re less likely to have a severe disease and potentially less likely to get long COVID,” said Commissiong.

He called this “a call to action,” considering many people who have had the virus have dealt with extended issues tasting, smelling, brain fog and even worse symptoms. Commissiong spoke of the necessity to develop a strategy in how to implement rapid tests. Without such a strategy in place, he recommends the PCR test for the holiday,

“The PCR test is really the best test if you are going to go and see people and are worried you could be carrying the disease,” said Commissiong.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's new white paper maps how digital health technologies can reshape CNS clinical trial endpoints

IQVIA's white paper provides a framework for validating digital endpoints in CNS clinical trials, focusing on digital health technologies such as sensors, software, and connected devices. These technologies have the potential to reshape clinical trial endpoints in neurological studies. The white paper aims to guide the integration of digital health solutions in measuring clinical outcomes.

  • 01Digital health technologies like sensors and software can reshape CNS clinical trial endpoints.
  • 02Validating digital endpoints in clinical trials is crucial for integrating technology in CNS studies.
  • 03IQVIA offers a framework for using connected devices in clinical research.

Jul 16, 2026

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

Clinical AI safety, intelligent ventilators, and payment accuracy: health tech's big moves on July 15

On July 15, significant health technology announcements highlighted advancements in AI safety benchmarks, smarter critical-care equipment, and autonomous front-office tools. These developments indicate a strong push towards integrating intelligent systems in healthcare to enhance patient care and operational efficiency.

  • 01AI safety benchmarks are being established to ensure intelligent technologies are safely integrated into healthcare systems.
  • 02Intelligent ventilators and smarter critical-care tools are being developed to improve patient outcomes in healthcare settings.
  • 03Autonomous front-office tools are being introduced to streamline administrative tasks in healthcare facilities.

Jul 16, 2026

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia's digital health push: what a $77 billion market means for enterprise operators

Saudi Arabia is set to expand its healthcare market with expenditures predicted to reach $77.1 billion by 2027, partly driven by advancements in digital health technologies. Digital health revenue is expected to exceed $1 billion by 2029, with an anticipated user base of 16.2 million. This growth represents significant opportunities for enterprise operators in the healthcare sector.

  • 01Saudi Arabia's healthcare spend is projected to reach $77.1 billion by 2027.
  • 02The digital health market in Saudi Arabia is expected to generate over $1 billion in revenue by 2029.
  • 03An estimated 16.2 million users will engage with digital health services in Saudi Arabia by 2029.

Jul 16, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512